Anete is a Full Professor of Internal Medicine at the Federal University of Rio de Janeiro. She is a senior investigator dedicated to tuberculosis (TB) elimination, coordinator of the clinical research session (and former president) at the Brazilian TB Network (Rede-TB). She was the PI in Brazil of several clinical trials on TB infection (TBI) detection and treatment, in collaboration with the McGill International Centre. She is currently leading a large operational study, initially funded by Stop Tb Partnership and currently funded by the Brazilian Ministry of Health, the Expand TPT. Through this program, the prescription of TPT to contacts increased by 73% in five Brazilian capitals. The program is now being extended to three other high TB burden cities and is based on lessons learned from the ACT-4 clinical trial.
Current research projects:
She also collaborates with Vanderbilt University in the Regional Prospective Observational Research in Tuberculosis - Brazil (RePORT-Brazil) project, led by Prof. Timothy Sterling. She acts as a reviewer of post-doctoral and fellowship grantees’ projects in the RePORT-Brazil Advanced Career Training (ReACT) program. The RePORT International is a partnership funded by the USA NIH, which prospectively collects epidemiological and clinical data as well as biological specimens from cohorts of people with TB and their contacts.
She has also acted as key personnel in the US-Brazil Clinical, Operational and Health Services AIDS/TB (ICOHRTA-AIDS/TB) project led, a collaboration with Johns Hopkins, Cornell and the University of California at San Francisco, led by Prof. Jose Roberto Lapa e Silva in Brazil, also funded by the FIC/NIH. Other ongoing and recent projects focus on efficacy, effectiveness, and cost-effectiveness of new regimens and diagnostics for TBI. She has supervised 30 graduate and 68 undergraduate students and published in most aspects that maintain TB as one of the leading causes of death in the world: poor prevention of the disease through preventive treatment of LTBI, drug-resistant TB, HIV-associated TB, and poverty as a social determinant of TB.
Email: atrajman [at] gmail.com
